<p>D384 cells were exposed to 12.5, 15 and 17.5 μM DhL for 16 h. Total protein lysates were separated by 12–15% SDS-PAGE followed by western blot analysis with the indicated antibodies against BAX, CDKN1A, TP53, S46-p-TP53, and p139-<b>γ</b>H2AX, as shown in Panel A, and TP73 and Y99-p-TP73, as shown in Panel B. <b>α</b>-Tubulin and ß-actin were used as loading controls for total cell extracts.</p
<p>A) Western blots for BCL-2 family proteins in HCT116 WT and Exn5/Exn5 cells treated with 500 ng/m...
(A) The expression of apoptotic marker proteins p53, Bax, Bad and cytochrome c, and anti-apoptotic m...
<p>The expression of some proteins measured at different treatment times, and involved in apoptotic ...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>Apoptotic D384 cells were detected and monitored by Annexin V-FITC/PI staining. (A) A representat...
<p>(A). The chemical structure of DhL (B). Analysis of D384 cell viability upon DhL exposure using a...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
<p>D384 cells were treated with 0, 5, 10, 15 and 20 μM DhL for 6 h, 16 h and 32 h, visualized under ...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p>Unsynchronized HeLa (A) and MCF-7 cells (B) and synchronized HeLa (C and D) cells were treated wi...
<p>Synchronized HeLa cells treated with 0–20 µM DhL for 48 h were analyzed for: (A) protein concentr...
<div><p>(A) DHC increases p53 lysine 373 and 382 acetylation in a dose-dependent manner in the TK6 c...
<p>(A) Western blot analysis of proteins p53, Bcl-2 and Bax in HepG2 cells with DHM treatment for 3,...
<p>L02 cells were exposed to different concentrations (1, 10, and 100 μg/mL) of HDL together with TM...
<p>Synchronized HeLa cells were treated with 0, 10, or 20 µM DhL and analyzed by phase contrast in l...
<p>A) Western blots for BCL-2 family proteins in HCT116 WT and Exn5/Exn5 cells treated with 500 ng/m...
(A) The expression of apoptotic marker proteins p53, Bax, Bad and cytochrome c, and anti-apoptotic m...
<p>The expression of some proteins measured at different treatment times, and involved in apoptotic ...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>Apoptotic D384 cells were detected and monitored by Annexin V-FITC/PI staining. (A) A representat...
<p>(A). The chemical structure of DhL (B). Analysis of D384 cell viability upon DhL exposure using a...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
<p>D384 cells were treated with 0, 5, 10, 15 and 20 μM DhL for 6 h, 16 h and 32 h, visualized under ...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p>Unsynchronized HeLa (A) and MCF-7 cells (B) and synchronized HeLa (C and D) cells were treated wi...
<p>Synchronized HeLa cells treated with 0–20 µM DhL for 48 h were analyzed for: (A) protein concentr...
<div><p>(A) DHC increases p53 lysine 373 and 382 acetylation in a dose-dependent manner in the TK6 c...
<p>(A) Western blot analysis of proteins p53, Bcl-2 and Bax in HepG2 cells with DHM treatment for 3,...
<p>L02 cells were exposed to different concentrations (1, 10, and 100 μg/mL) of HDL together with TM...
<p>Synchronized HeLa cells were treated with 0, 10, or 20 µM DhL and analyzed by phase contrast in l...
<p>A) Western blots for BCL-2 family proteins in HCT116 WT and Exn5/Exn5 cells treated with 500 ng/m...
(A) The expression of apoptotic marker proteins p53, Bax, Bad and cytochrome c, and anti-apoptotic m...
<p>The expression of some proteins measured at different treatment times, and involved in apoptotic ...